Press Releases from Creative Diagnostics (13 total)
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facili …
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has recently announced a series of new Anti-Small Molecule Label Antibodies to facilitate the development of nucleic acid lateral flow immunoassay (NALFIA). These antibodies can specifically bind to small molecule labels and offer customers multiple choices, including Anti Digoxin monoclonal antibodies, Anti-Fluorescien monoclonal antibodies, and Anti-FAM polyclonal antibodies.
Traditional nucleic acid detection methods require trained operators and sophisticated…
Creative Diagnostics Introduces New ELISA Kits to Accelerate Autoimmunity Resear …
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced a series of new ELISA Kits to assist researchers in studing the mechanisms of autoimmunity, including those associated with anti-neotrophil, anti-nuclear, rheumatic diseases, endocrine autoantibodies, and the neurological system.
The immune system has very powerful effector mechanisms to destroy a wide range of pathogens. Early in the study of immunity, it was recognized that if these…
Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the launch of new reagent solutions for herpesvirus research, including a range of Human Herpesviruses Antibodies designed to help researchers better understand the structure of Herpesvirus entry and develop new treatments and prevention strategies.
The Herpesviridae are a large family of double-stranded DNA enveloped viruses that cause a variety of diseases. The nine human herpesviruses are…
Creative Diagnostics Launches Highly Specific Antibodies Against FXIIIa/F13A1 fo …
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens, and assay kits, has launched a set of highly specific antibodies against FXIIIa/F13A1 for vascular diseases. These antibodies can be used in various scientific applications such as WB, ELISA, IHC, and IP to facilitate drug development research.
Coagulation Factor XIIIa (FXIIIa) is a plasma transglutaminase that catalyzes the final step of the coagulation process and plays an important role in hemostasis.…
Creative Diagnostics Launches Monkeypox Virus Antibodies and Antigens to Support …
Creative Diagnostics, a global leader in offering raw materials, antibodies, and reagents for the bio-technology industry, announced the launch of several Monkeypox Virus Antibodies and Antigens that have been validated to work in various types of immunoassays and can be used as tools for the detection of Monkeypox viruses.
Monkeypox virus (MPV or MPXV) is a double-stranded DNA virus that causes monkeypox in humans and other animals. It belongs to the…
Creative Diagnostics Launches Antibody-dependent Enhancement Assay Services
As a consulting and experimental service provider specializing in virology and microbiology, Creative Diagnostics recently introduces comprehensive services for antibody-dependent enhancement (ADE) assay. Flow cytometry, plaque assay or qPCR method are used to evaluate the ADE effect of test articles on virus infection in Fc receptor bearing cells.
Antibody-dependent enhancement mainly refers to effects in the body caused by pathogen infection. In 1964, Hawkes and his team at the Australian National…
Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies
As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches a series of NiV recombinant antigen and antibody pairs. All of these new products are produced using standardized production processes to ensure the highest quality. Tests developed using these reagents can assist researchers in routine diagnostics and NiV vaccine development.
Nipah virus (NiV) was initially isolated and identified in 1999 during an outbreak…
Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens
As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches a range of natural and recombinant staphylococcal enterotoxin antigens that are well validated in double-antibody sandwich enzyme-linked immunosorbent assay (ELISA). The newly introduced antigens consist of five of the most common staphylococcus aureus enterotoxins and are ideal for in vitro detection and diagnostic studies.
Staphylococcus aureus is a Gram-positive spherical bacterium about 1…
Creative Diagnostics Broadens Its Portfolio with New Pseudotyped GFP HPV
As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently introduces new Pseudotyped GFP HPV for immunogenicity assessment in vaccine trials. This new series of HPV reporter virus particles can be used for measuring neutralizing anti-HPV antibodies in pseudovirion-based neutralization assays.
Human papillomaviruses (HPVs) are double-stranded non-enveloped DNA viruses that infect keratinocytes of stratified squamous epithelia. Immunogenicity assessments in vaccine trials have focused…
Creative Diagnostics Launches Fluorescently Labeled Gold Nanoparticles for Cellu …
With years of experience in the pharmaceutical and life science sector, Creative Diagnostics introduces a series of fluorescently labeled gold nanoparticles for efficient cell uptake, such as DiagNano™ Fluorophore Labeled Gold Nanoparticles, 10 nm, Cellular Uptake(GFL-10-CU), and DiagNano™ Fluorophore Labeled Gold Nanoparticles, 50 nm, Cellular Uptake (GFL-50-CU). These new products can be potentially used for cancer diagnostics, studies, and immunoassays.
Colloidal and intracellular gold nanoparticles can be validated by confocal microscopy.…
Creative Diagnostics Introduces the Launch of Beta Actin Antibody
As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently expanded antibody portfolio with the launch of a series of beta actin antibody for ICC/IF, WB, and IHC-P. These new products are only for research use, and are not intended for diagnostic use.
Creative Diagnostics offers primary antibodies to multiple forms of virtually every protein in the proteome, and secondary antibodies that are…
Creative Diagnostics Supports COVID-19 Testing with Antigen Lateral Flow Assay D …
As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now introduces COVID-19 Antigen Lateral Flow Assay Development, including the SARS-CoV-2 nucleoprotein antibody pair for rapid COVID-19 antigen assays to equip healthcare workers for rapid COVID-19 antigen detection. Additionally, Creative Diagnostics also offers SARS-CoV-2 antigen extraction buffer tubes that can be used as packing supplies for SARS-CoV-2 antigen extraction.
The global COVID-19 pandemic has…
ACE2 Products Are Available at Creative Diagnostics to Advance SARS-CoV-2 Resear …
With COVID-19 rapidly spreading globally, scientists all over the world are devoted to related researches, trying to find an effective vaccine or drug to stop this epidemic. Angiotensin-converting enzyme 2 (ACE2) is an integral membrane protein with considerable homologous to ACE, which belongs to the peptidase M2 family. In case of human coronaviruses SARS and HCoV-NL63 infections, ACE-2 serves as a functional receptor for the spike glycoprotein of both coronaviruses.…
